direction pharma aps: Financial statements 2017
CVR: 36948884
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
direction pharma aps (CVR 36948884) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -20,891 and a net result of DKK -21,221. Equity in the 2017 report amounted to DKK 62,289. The solvency ratio was 92.6%.
- Gross Profit
- DKK -20,891
- Profit/Loss
- DKK -21,221
- Equity
- DKK 62,289
- Total Assets
- DKK 67,289
- Employees
- 0
Keep an eye on direction pharma aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Direction pharma aps has published its interim report for the period July 2, 2015 – December 31, 2016.
About direction pharma aps
direction pharma aps was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015 and dissolved in 2019. The company was registered under the industry Anden teknisk rådgivning. In 2017, the company reported a gross profit of DKK -20,891 and a net result of DKK -21,221. Equity in the 2017 report amounted to DKK 62,289.